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ABSTRACT
PURPOSE: To compare the different quality of life measures used to report the outcomes of the different 
forms of management of vestibular schwannomas.
METHODS: Literature search and critical evaluation of outcome measures and comparison between dif-
ferent studies. 
RESULTS: A total number of 6749 patients were included in 31 studies. Eighteen studies used the SF36 
forms, 17 – custom questionnaires, 7 – the GBI and 8 used various other questionnaires. The most com-
monly reported handicaps included hearing loss, facial nerve paralysis, tinnitus, gait and balance disor-
ders, pain and headache, psychological and cognitive problems, loss of taste and lacrimation and facial hy-
poesthesia.
CONCLUSIONS: When evaluating QOL issues in patients with vestibular schwannoma, the type of inter-
vention as well as the pre-interventional status should be considered. More specific comprehensive systems 
of evaluation should be devised through the cooperation of multiple centers with different management pol-
icies and variable patient populations as well.
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INTRODUCTION
Vestibular schwannomas are benign tumours 
with minimal early symptoms, but considerable mor-
bidity can result during their natural progression or 
subsequent to treatment. Consequently, QOL issues 
become of paramount importance when consider-
ing treatment options. The current methods of man-
agement have entirely different goals. Surgery aims 
at completely removing tumors, radiosurgery aims 
to control tumor growth whereas radiologic surveil-
lance aims to manage patients by serially measur-
ing tumor size on the assumption that a significant 
proportion of vestibular schwannomas do not grow 
(1,2). The perception of treatment outcomes also dif-
fer between the surgeons and their patients. The im-
pact of different treatment modalities on the patient’s 
QOL using the general impairment, disability and 
handicap scales may not reflect the specifics of the 
disease and the consequences of its management (3, 
4). Disease-related measures should be designed to 
assess the true impact of treatment options and as-
sist in a comprehensive discussion with patients, pre-
planning of rehabilitative processes and long-term 
support of the patients regarding vocational and so-
cial issues. The aim of this work is to review the re-
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cent literature on the effects of management on vari-
ous quality of life indices and attempt to sort out the 
most relevant points, which need to be included in 
any scheme to help in the decision making and coun-
seling of patients. 
MATERIAL AND METHODS
A search was performed on PubMed with the 
following search criteria:
 ❖ vestibular schwannoma/acoustic neuroma; 
 ❖ microsurgery; 
 ❖ gamma knife/radiation; 
 ❖ conservation/wait and rescan/wait and see; 
 ❖ follow-up; 
 ❖ quality of life measures; 
 ❖ in humans and in English language.
Thirty-one representative studies were includ-
ed (1996-2010). All articles described the effect of one 
or more management policies on the patients’ quality 
of life. Each article was analyzed for the type of man-
agement, the method of assessment and the main 
conclusion as regards the highest impact of the man-
agement policy on the patients’ quality of life. The re-
sults were compared and a list of the most important 
causes of impairment made. 
RESULTS
A total number of 6 749 patients were includ-
ed, 5 252 underwent surgery, 874 –radiosurgery and 
470 were scheduled for a wait and see policy. Of these 
studies, 18 used the SF36 forms, 17 – custom ques-
tionnaires, 7 – the GBI and 8 used various other ques-
tionnaires. Sixteen studies used more than one eval-
uation form. In all studies, age, gender, tumor size or 
audiometric data did not lead to any statistical dif-
ferences in the result. Women tended to have lower 
scores, but this finding is present in normative data.
The most commonly reported handicaps in-
cluded hearing loss, facial nerve paralysis, tinnitus, 
gait and balance disorders, pain and headache, psy-
chological and cognitive problems, loss of taste and 
lacrimation and facial hypoesthesia.
Custom questionnaires:
Hearing loss is one of the major effects of ther-
apy (5). However hearing impairment was not a ma-
jor factor that impacted patients’ QOL after surgery; 
but paradoxically, hearing preservation did not lead 
to an improvement in the reported measures (6). It is 
assumed that patients had already experienced some 
degree of hearing loss prior to surgery and most were 
acquainted with a changed lifestyle. 
The second commonest handicap was facial 
nerve dysfunction including taste and salivation. The 
impact of facial paralysis and sensory impairments 
varies between studies from insignificant to ex-
tremely troublesome (7-9). Facial nerve impairment 
and physical pain were the two major symptom fac-
tors that had a significant impact on QOL of patients 
after surgery. These two symptoms together might 
result in weakened psychological adjustment to ill-
ness in the area of social, vocational, and domestic 
environment, as well as patients’ sexual relations (4).
Loss of balance and pain variably affected pa-
tients’ quality of life. In some studies, the effect was 
not significant whereas in others they are usually as-
sociated with a significant negative impact on social 
functioning (10). Hearing and balance domains re-
flect not just symptom scores but also functional and 
societal limitations and so it made sense that these 
domains correlated most strongly with the SF-36 
physical role limitation domain (11).
Psychosocial morbidity such as depression, 
anxiety and loss of confidence may be present in up 
to a quarter of surveyed patients. Fatigue appeared 
to be associated with other symptoms such as hear-
ing impairment, balance disturbance and facial pa-
ralysis. For example, listening, walking and/or enun-
ciation had become more difficult and therefore re-
quired higher levels of concentration. Hearing loss 
was a more difficult symptom than facial paralysis 
because it interfered with communication. Anxiety 
was also related to hearing problems. (7,12,13). The 
participants who reported higher levels of psycholog-
ical wellbeing were those who experienced less severe 
physical symptoms and believed that they had re-
ceived a good treatment outcome. Uncertainty about 
prognosis was more prevalent among radiation pa-
tients (14).
General questionnaires:
In the articles using SF36 or SF12 forms, the 
most frequently reported handicaps were a dimi-
nution in physical, role physical and mental items. 
Hearing loss was the most distressing handicap fol-
lowed by facial paralysis. Paradoxically, hearing pres-
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ervation did not improve SF36 scores and facial dys-
function did not lower the scores. There was no sig-
nificant difference in terms of Glasgow Benefit In-
ventory scores between patients with and without fa-
cial dysfunction, nor between those with different 
House-Brackmann grades (15). Lower scores in so-
cial functioning were due to balance problems not 
hearing loss. A study on 199 patients using well-rec-
ognized questionnaires suggested that vertigo is the 
symptom which causes the most pronounced nega-
tive effect on scores for quality of life with unilater-
al hearing loss and tinnitus having less effect (16). In-
creased numbers of postoperative symptoms and/or 
larger tumors are associated only with worse physical 
functioning. More bodily pain results in a more neg-
ative perception of general health as well as continu-
ous medical consultation (15-18). 
In addition, the perception of morbidity var-
ies with age and gender. In order of frequency, men 
reported hearing loss, balance problems, periopera-
tive surgical experience, and eye and facial weakness, 
and women reported hearing loss, facial weakness, 
eye problems, and headache. Facial weakness was a 
morbidity more often reported for men and wom-
en who had large tumors, who were young, or who 
had undergone the retrosigmoid approach. Balance 
dysfunction was significant in patients older than 
75 years of age. In patients with small tumors, head-
aches and balance problems were frequently report-
ed (19). The distress experienced by patients with fa-
cial paralysis following vestibular schwannoma sur-
gery does not correlate with the grade of the paraly-
sis as attributed by surgeons. Patients with minimal 
disturbance of facial nerve function may experience 
great personal distress (7,13).
There were more impairments 51% (hear-
ing loss, balance) than disabilities 34% (difficulty in 
sound localization, eating problems) and more dis-
abilities than handicaps 15% (reluctance to attend 
large gatherings, loss of work) (12).
This ability to resume daily activities was inde-
pendent of the occurrence of hearing problems, in 
contrast to ataxia, dysgeusia and headache and facial 
paresis SF-36 has demonstrated, however, that only 
headache, and not age, sex, hearing or facial function 
after surgery, was associated with lower scores in any 
category (physical role limitations and bodily pain). 
Headache and facial problems were furthermore the 
main reason for continuous medical consultation in 
about one-third of patients after surgery (18-20).
In most reviewed studies the QOL of patients 
undergoing radiotherapy was better than any form 
of surgery; patients in the wait and see groups had 
obviously no change in their quality of life post-di-
agnosis. One study found no differences in all three 
groups over a 24 months follow-up (1). Surgical exci-
sion had a significant reduction in the domains of so-
cial functioning and role limitations due to physical 
functioning. These populations cannot be compared 
directly as the populations were different in both age 
and tumor size (patients managed by interval scan-
ning were older and had smaller tumors).
DISCUSSION
Three main policies are now accepted, watch-
ful waiting, surgery and radiotherapy. Each has its 
indications, its risks and its effect on patients’ qual-
ity of life. The estimation of possible risks and ben-
efits for the patient is of utmost importance in deci-
sion-making (27). The evaluation of quality of life is-
sues can be done using standard forms (SF36, etc.), 
specific handicap indices (DHI, etc.) or custom ques-
tionnaires (PANQOL). Most of these tools, although 
exceedingly valuable, do not provide a global view of 
the problem in a patient-oriented perspective taking 
in consideration the particularities of each therapeu-
tic approach. 
The main post-therapeutic sequels include 
hearing loss, facial nerve dysfunction, balance dis-
orders, pain, other cranial nerve dysfunctions and 
psychological problems. Any QOL measure should 
look at both pre-existing handicaps and post-inter-
ventional changes in each factor. The pathology is 
the same but the methods of managements are com-
pletely different in both their aim and impact. QOL 
evaluation forms for vestibular schwannomas should 
be modified according to the type of management. 
It is illogical to list hearing loss as an important 
issue after translabyrinthine excision in patients who 
did not have pre-operative serviceable hearing es-
pecially that hearing preservation was not associat-
ed with any improvement in QOL after surgery. Fa-
cial paralysis is a devastating event, which can affect 
many social and professional functions. Its psycho-
logical effect is also significant (21). Patients sched-
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uled for surgery with impaired hearing due to AN 
had enough time to adjust their lives for unilateral 
hearing and thus will not be further affected. On the 
other hand patients undergoing GK treatment do not 
expect any hearing deterioration (as widely adver-
tised on the internet or in centers offering this ther-
apy) and thus with any deterioration of hearing they 
will start complaining albeit after a variable interval.
Acute post-operative gait and balance distur-
bances are less commonly reported but may affect 
physical functioning and professional rehabilitation 
as well as sports and other leisurely activities. Pa-
tients may need early gait and balance rehabilitation 
or a change in vocation (22).
Facial pain and headache have been reported by 
patients as distressing and may adversely affect their 
psychological outcome and increase their morbidity 
and dependence.
Psychological problems such as anxiety, frustra-
tion and depression have been reported by patients 
diagnosed with many diseases. In the case of patients 
with vestibular schwannomas they are aware that it 
is a benign disorder that can be effectively controlled. 
In most studies reporting on this issue, the strongest 
determinant factor was social support and counsel-
ing. Post-treatment resumption of activities and jobs 
were also associated with a better psychological out-
come. However, excessive care may lead to undue de-
pendence and prolonged time out of work. Neuro-
psychological investigations for cognitive and mnes-
tic performance following procedures in the cerebel-
lopontine angle have highlighted problem areas re-
ceiving hitherto little attention (12-14).
Patient selection is not random. Most patients 
scheduled for a wait and see policy have small tu-
mors, near normal hearing and minimal initial mor-
bidity. Patients selected for GKS have in principle tu-
mors <3 cm, near normal hearing and may be old-
er. On the other hand patients undergoing microsur-
gery tend to have larger tumors, poorer initial hear-
ing and possibly other morbidities (2,23,24). Similar-
ly, morbidities may appear over a long period of time 
so that delayed effects should be taken into consider-
ation and an actuarial model of progressive and de-
layed morbidity should be applied especially in pa-
tients undergoing GK therapy or in a wait and see 
program. Although surgery is associated with the 
highest rate of acute morbidity and the highest im-
mediate effect on the QOL of patients, the effects 
tend to diminish over time whereas in the two oth-
er strategies the effects tend to increase. Tumor con-
trol with radiotherapy is reasonable (25, 26) but there 
are a number of complications which progress over 
time, namely: hearing loss, facial paralysis, trigemi-
nal neuropathy, hydrocephalus, vascular injuries and 
the possibility of malignant transformation (27-32).
Conservative management of vestibular 
schwannomas carries difficulties: long-term follow-
up of the patients and unpredictability of the tumor 
growth pattern. A reliable and reproducible radiolog-
ic method for evaluating tumor size is of great im-
portance. Sequential MRI cannot be substituted by 
audiologic examinations solely because increase in 
VS volume does not correlate with audiologic dete-
rioration significantly (33-35). Wait and see is not 
associated with any active intervention and follows 
the natural history of the disease. When the tumor 
starts to grow and/or cause additional symptoms, 
only then should the patients be included in the sur-
veys (36). Surgery is often associated with immedi-
ate effects but some improve or can be corrected over 
time. Radiation therapy carries minimal immedi-
ate morbidity but possible (so far incompletely clear) 
long term effects (39). Reporting QOL issues in this 
context should consider both short and long term ef-
fects (26,36).
Thus, patients should be counseled regarding 
this risk and generic QOL measures such as the SF-
36 should be used with caution in future assessments 
(37). 
CONCLUSIONS
When evaluating QOL issues in patients with 
vestibular schwannoma, the type of intervention as 
well as the pre-interventional status should be con-
sidered (38). The pathology is the same but the meth-
ods of managements are completely different in both 
their aim and impact. Any QOL evaluation in such 
patients should emphasize the following: hearing, 
balance and facial paralysis grading and their ef-
fect on social and professional performance; gener-
al performance as well as the psychological sequels 
of management.
Standard forms are inadequate to cover the all 
the functional aspects of the problem. Generic forms 
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on the other hand cannot differentiate between the 
different forms of management. Thus more specific 
comprehensive systems of evaluation should be de-
vised through the cooperation of multiple centers 
with different management policies and variable pa-
tient populations as well.
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